Topical application of Cinnamomum hydroethanolic extract improves wound healing by enhancing re-epithelialization and keratin biosynthesis in streptozotocin-induced diabetic mice

Pharm Biol. 2019 Dec;57(1):799-806. doi: 10.1080/13880209.2019.1687525.

Abstract

Context: Cinnamomum verum J. Presl. (Lauraceae) has a high number of polyphenols with insulin-like activity, increases glucose utilization in animal muscle, and might be beneficial for diabetic patients.Objective: This study evaluated the effectiveness of an ointment prepared from Cinnamomum verum hydroethanolic extract on wound healing in diabetic mice.Materials and methods: A total of 54 male BALB/c mice were divided into three groups: (1) diabetic non-treated group mice that were treated with soft yellow paraffin, (2 and 3) mice that were treated with 5 and 10% C. verum. Two circular full-thickness excisional wounds were created in each mouse, and the trial lasted for 16 d following induction of the wound. Further evaluation was made on the wound contraction ratio, histopathology parameters and mRNA levels of cyclin D1, insulin-like growth factor 1 (IGF-1), glucose transporter-1 (GLUT-1), total antioxidant capacity, and malondialdehyde of granulation tissue contents. HPLC apparatus was utilized to identify the compounds.Results: The HPLC data for cinnamon hydroethanolic extract identified cinnamaldehyde (11.26%) and 2-hydroxyl cinnamaldehyde (6.7%) as the major components. A significant increase was observed in wound contraction ratio, fibroblast proliferation, collagen deposition, re-epithelialization and keratin biosynthesis in the C. verum-treated groups in comparison to the diabetic non-treated group (p < 0.05). The expression level of cyclin D1, IGF1, GLUT 1 and antioxidant capacity increased in the C. verum-treated groups in comparison to the diabetic non-treated group (p < 0.05).Conclusions: Topical administration of C. verum accelerated wound healing and can possibly be employed in treating the wounds of diabetic patients.

Keywords: Antioxidant activity; cinnamaldehyde; glucose transporter-1; insulin-like growth factor 1.

MeSH terms

  • Administration, Topical
  • Animals
  • Antioxidants / adverse effects
  • Cinnamomum / chemistry*
  • Diabetes Mellitus, Experimental / chemically induced
  • Insulin-Like Growth Factor I / metabolism
  • Keratins / biosynthesis
  • Keratins / drug effects*
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Ointments
  • Plant Extracts / pharmacology*
  • Polyphenols
  • Re-Epithelialization / drug effects*
  • Skin / drug effects
  • Streptozocin / pharmacology
  • Wound Healing / drug effects*

Substances

  • Antioxidants
  • Ointments
  • Plant Extracts
  • Polyphenols
  • Streptozocin
  • Insulin-Like Growth Factor I
  • Keratins